600763 通策医疗
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入2,233,1272.21%2,846,5082,718,6122,780,7252,087,865
减:营业总成本1,606,4524.34%2,199,9662,029,1511,873,0831,452,287
    其中:营业成本1,299,3133.57%1,749,7541,609,0251,500,0001,144,870
               财务费用35,90851.39%49,58946,55323,02015,227
               资产减值损失------------
公允价值变动收益------------
投资收益37,38710.29%60,19338,30156,13438,863
    其中:对联营企业和合营企业的投资收益26,65374.24%34,80010,74812,39613,086
营业利润670,056-2.07%711,922733,906974,891678,640
利润总额667,891-2.22%708,858737,984974,584680,066
减:所得税费用66,130-6.94%130,434122,306188,434135,104
净利润601,761-1.68%578,423615,678786,150544,962
减:非控股权益103,4903.19%77,94967,40983,34352,336
股东净利润498,271-2.63%500,475548,269702,807492,625

市场价值指针
每股收益 (元) *1.110-2.63%1.5601.7102.1901.540
每股派息 (元) *----0.436------
每股净资产 (元) *9.225-22.53%11.86710.3258.9846.706
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容